Physician profile
Robert G Taylor
NPI 1447339544
$2,042.05
in general payments reported to CMS, 2019-2025
11 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $153 · 2021: $144 · 2022: $212 · 2023: $510 · 2024: $511 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,295.99 | 2019-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Stryker Corporation | $317.41 | 2023 | Spy-Phi System, 1788 |
| Abbvie INC. | $144.00 | 2024-2025 | |
| Allergan, INC. | $92.90 | 2020-2022 | |
| Galderma Laboratories, L.P. | $60.89 | 2021-2025 | |
| Motiva USA, LLC | $35.62 | 2025 | |
| Baudax Bio INC. | $23.72 | 2021 | |
| Rti Surgical, INC | $20.57 | 2022 | |
| Csl Behring | $17.80 | 2021 | |
| Sientra, INC. | $16.72 | 2020 | |
| Arteriocyte Medical Systems, INC. | $16.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.